News

Filter

Current filters:

Botulinum Toxin Type A

1 to 9 of 65 results

Espicom views Allergan’s performance, products, pipeline and potential

21-08-2009

Allergan, with headquarters in Irvine, California, USA, is a global specialty pharmaceutical company…

AllerganBotoxBotulinum Toxin Type ABotulinum Toxin Type BMyoblocNorth AmericaPharmaceutical

FDA asks for more info on new Botox indication

28-05-2009

The US Food and Drug Administration has delayed approving Allergan's Botox (botulinum toxin type A) for…

Abobotulinumtoxin A InjectionAllerganBotoxBotulinum Toxin Type ADysportIpsen

Stock Commentary - Europe - week to April 27, 2009

30-04-2009

EUROPEAN: bourses were mostly significantly higher over the reporting week to April 27, with STOCKHOLM…

AvastinAventis PharmabevacizumabBotoxBotulinum Toxin Type AGenentechGlaxoSmithKlineGSKIpsenRocheSanofi-Aventis

Stock Commentary - Europe - week to April 20, 2009

23-04-2009

EUROPEAN: bourses headed higher for most of the reporting week to April 20, but plunged on the last day,…

AstraZenecaAventis PharmaBotoxBotulinum Toxin Type AGlaxoSmithKlineGSKIpsenNovartisRocheSanofi-AventisSolvay

Ipsen and Medicis are in talks to resolve delays to US approval of Reloxin

16-04-2009

French drugmaker Ipsen and US partner Medicis are in talks with the Food and Drug Administration to resolve…

BotoxBotulinum Toxin Type AIpsen

1 to 9 of 65 results

COMPANY SPOTLIGHT

Menarini

Back to top